Search results
Plenary Papers. EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma. Ola Landgren; Thomas J. Prior; Tara Masterson; Christoph Heuck; Orlando F. Bueno; Ajeeta B. Dash; Hermann Einsele; Hartmut Goldschmidt; Stefan Knop; Cong Li; Ulf-Henrik Mellqvist; Ian McFadden; Corina Oprea ...
Blood, the flagship journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on …
American Society of Hematology. 2021 L Street NW, Suite 900. Washington, DC 20036. TEL +1 202-776-0544. FAX +1 202-776-0545. ASH Publications. Blood. Blood Advances. Blood Neoplasia.
Jul 18, 2024 · AK2 suppression decreased nicotinamide adenine dinucleotide phosphate, leading to replication stress, DNA damage, and apoptosis, identifying a novel metabolic vulnerability in t (4;14) MM, driven by aberrant epigenomic carbon transfer. View Article.
Read the latest articles of Blood at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature.
Read the latest articles of Blood at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Blood is a peer-reviewed medical journal published by the American Society of Hematology. It was established by William Dameshek in 1946. The journal changed from semimonthly (24 times annually) to weekly publication at the start of 2009.
